Order results by:
| Issue | Title | |
| Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
| N. N. Petrova | ||
| "... , highlights the issues of adherence to antidepressant therapy, investigation of the safety and efficacy ..." | ||
| Vol 14, No 1 (2022) | Impact of different classes of antidepressants on sleep and wakefulness regulation in depression | Abstract similar documents |
| G. M. Usov, D. Yu. Kolomytsev, L. M. Lomiashvili | ||
| "... are of particular value in clinical practice. Agomelatine (valdoxan) rapidly improves sleep in depressed patients ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... the high efficiency and good tolerability of agomelatine, an antidepressant with an innovative mechanism ..." | ||
| Vol 15, No 5 (2023) | Diagnosis and treatment of depression according to the functional recovery paradigm | Abstract similar documents |
| G. M. Usov | ||
| "... that provides a broader therapeutic effect combined with a more favorable tolerability profile. Agomelatine ..." | ||
| Vol 15, No 2 (2023) | Depression in patients with cerebral microangiopathy | Abstract similar documents |
| A. N. Bogolepova | ||
| "... and safety should be preferred. Agomelatine (Valdoxan) is one of such drugs. ..." | ||
| Vol 3, No 2 (2011) | Role of melatonin in the treatment of depression | Abstract similar documents |
| O. V. Kotova | ||
| "... a wide range of drugs that are able to affect melatonin metabolism, amongst which there is agomelatine ..." | ||
| Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
| D. V. Romanov, B. A. Volel, D. S. Petelin | ||
| "... This review provides information on prospects for using the antidepressant agomelatine ..." | ||
| Vol 16, No 4 (2024) | Agomelatine: pharmacological profile, possible application, advantages | Abstract similar documents |
| V. E. Medvedev, O. V. Kotova, A. V. Palin, O. V. Mikheeva, E. S. Akarachkova | ||
| "... Agomelatine is an antidepressant with a unique pharmacological action that is both a melatonin ..." | ||
| Vol 11, No 2 (2019) | Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression | Abstract similar documents |
| L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova | ||
| "... Objective: to develop and justify differentiated indications for the use of agomelatine (valdoxan ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... Therapy of depression is a current problem in psychiatry. Agomelatine is not inferior to other ..." | ||
| Vol 12, No 4 (2020) | Depressions with eating disorders: clinical manifestations and therapy | Abstract similar documents |
| V. E. Medvedev, V. I. Frolova, E. V. Gushanskaya, Yu. S. Fofanova, S. E. Martynov, N. L. Zuikova, A. M. Burno, S. V. Nekrasova, I. V. Salyntsev | ||
| "... with the antidepressant agomelatine (25–50 mg/day at night) for depressions with two ED variants: hyperphagic (n=32 ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... coronavirus infection. Objective: to evaluate the antidepressant efficacy and tolerability of agomelatine ..." | ||
| Vol 13, No 6 (2021) | Treatment of mixed anxiety and depressive disorder: results from a observational study of the efficacy and tolerability of agomelatine | Abstract similar documents |
| D. S. Petelin, I. V. Niinoya, O. V. Sorokina, D. V. Troshina, O. N. Voskresenskaya, B. A. Volel | ||
| "... Objective: to study the efficacy, safety and tolerability of agomelatine in mixed anxiety ..." | ||
| Vol 6, No 3 (2014) | Analysis of reasons for low adherence to antiepileptic therapy in patients with symptomatic epilepsy | Abstract similar documents |
| M. A. Vagina, L. I. Volkova | ||
| "... Objective: to study the major factors that influence treatment adherence. Patients and methods ..." | ||
| Vol 14, No 2 (2022) | Treatment of mental disorders of generative cycle in women | Abstract similar documents |
| V. E. Medvedev | ||
| Vol 4, No 3 (2012) | Efficacy of valdoxan in the prevention and treatment of post-stroke depression | Abstract similar documents |
| Dina Rustemovna Khasanova, Yu V Zhitkova, A A Safiullina | ||
| "... The efficacy of valdoxan (agomelatine) used to prevent and treat post-stroke depression ..." | ||
| Vol 11, No 4 (2019) | Clinical and functional remission assessment in patients with recurrent depression | Abstract similar documents |
| N. N. Petrova | ||
| "... using agomelatine as an example. Conclusion. When assessing the results of treatment for depression ..." | ||
| Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
| M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
| "... (RDD – 93.2%; PD – 91.5%) compared to other regimens. Agomelatine was the most frequently used (31 ..." | ||
| Vol 13, No 2 (2021) | Drug-induced (medication-induced) depression in neurology practice | Abstract similar documents |
| E. Yu. Ebzeeva, O. D. Ostroumova, S. V. Batyukina, T. M. Ostroumova, A. I. Kochetkov, A. A. Kirichenko | ||
| "... . Its development leads to a decrease in treatment adherence, and in some cases, to discontinuation ..." | ||
| Vol 13, No 4 (2021) | Medication adherence in migraine patients (data of an online survey) | Abstract similar documents |
| N. A. Kovalchuk, E. A. Kiryanova, G. R. Tabeeva | ||
| "... Patient needs, drug intake patterns, and adherence to therapy are significant challenges ..." | ||
| Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
| "... The most important component of the treatment effectiveness is the adherence of patients ..." | ||
| Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
| E. A. Kovalenko, A. N. Bogolepova | ||
| "... Adherence to long-term medication is one of the most important components of effective therapy ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... for higher adherence to treatment and its higher efficiency. ..." | ||
| Vol 16, No 5 (2024) | The Effect of Adding Agomelatine to Escitalopram in the Treatment of Major Depressive Disorder | Abstract PDF (Eng) similar documents |
| H. Azadi, P. Rashidpour, S. M. Yassini Ardekani, M. Nadi Sakhvidi, H. Afshang, R. Bidaki | ||
| "... of depression is agomelatine. Objective of this study was to evaluate the effect of adding agomelatine ..." | ||
| Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
| E. V. Yakovenko, F. A. Abbasov | ||
| "... and cognitive functions, can significantly improve the quality of life of patients and their adherence ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
| Vol 14, No 5 (2022) | Emotional disorders and their therapy in chronic low back pain | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova, A. Kh. Mukhametzyanova | ||
| "... on dopamine reuptake, interaction with sigma receptors, low incidence of side effects, and high adherence ..." | ||
| Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
| P. N. Vlasov | ||
| "... ultimately lowers patient adherence to therapy. Pharmaceutical technologies ensuring a delayed release ..." | ||
| Vol 13, No 2 (2021) | Possibilities of using laboratory biomarkers for the objective diagnosis of depressive disorders | Abstract similar documents |
| V. K. Shamrey, E. S. Kurasov, Ya. S. Zobin, N. V. Tsygan | ||
| "... depression who had received 4-week monotherapy with agomelatine 25 mg/day. Results and discussion ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| "... of neurogenesis. The efficiency of treatment is known to be associated with patient medication adherence ..." | ||
| Vol 6, No 2 (2014) | Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization | Abstract similar documents |
| D.S. Danilov | ||
| Vol 16, No 4 (2024) | Difficulties in the diagnosis of depression in somatic and neurological practice: clinical observation | Abstract similar documents |
| N. A. Tyuvina, T. N. Maximova, S. V. Prokhorova, E. A. Kamelina | ||
| "... Депрессия довольно часто развивается на фоне соматической и неврологической патологии, но ..." | ||
| Vol 2, No 4 (2010) | Depression in Parkinson's disease | Abstract similar documents |
| M. R. Nodel' | ||
| "... только двигательных, но и нервно-психических нарушений. Депрессия встречается в среднем у 40-50 ..." | ||
| Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
| T. G. Voznesenskaya | ||
| "... Обсуждается актуальная проблема депрессии при цереброваскулярных заболеваниях. Приводятся ее ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular depression and cognitive dysfunction | Abstract similar documents |
| A. N. Bogolepova | ||
| "... Сосудистая депрессия является весьма частым и серьезным осложнением цереброваскулярных заболеваний ..." | ||
| Vol 9, No 3 (2017) | A chronobiological approach to therapy for depression | Abstract similar documents |
| M. Yu. Gerasimchuk | ||
| "... генетической предрасположенности повышает риск возникновения и хронизации депрессии. Для решения этой проблемы ..." | ||
| Vol 1, No 3-4 (2009) | DEPRESSION AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| L. V. Romasenko | ||
| "... По результатам комплексной оценки больных кардиологического стационара, страдающих депрессией ..." | ||
| Vol 10, No 3 (2018) | Clinical features of depression in women compared with men | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, E. O. Voronina, V. V. Balabanova, Yu. G. Tyulpin | ||
| "... Цель исследования – изучение клинических особенностей депрессии у женщин в сравнении с мужчинами ..." | ||
| Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Analysis of affective disorders in patients with vascular dementia | Abstract similar documents |
| D. V. Zakharchenko, N. G. Neznanov, N. M. Zalutskaya | ||
| Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
| I. V. Milyukhina | ||
| "... Депрессия – самое частое немоторное проявление болезни Паркинсона (БП), существенно влияющее на ..." | ||
| Vol 9, No 3 (2017) | The typology and clinical features of depressions during a period of remission in paroxysmal schizophrenia | Abstract similar documents |
| N. A. Tyuvina, D. O. Magomedova, V. D. Morozova | ||
| "... Депрессии у больных шизофренией в период ремиссии встречаются довольно часто, однако их генез и ..." | ||
| Vol 5, No 3 (2013) | Role of anxiety and depressive disorders in the genesis of psychosomatic disorders | Abstract similar documents |
| Aleksandr Anatolyevich Shatenshtein | ||
| "... группах психосоматических заболеваний. У пациентов этих групп рост тревоги и депрессии усугубляет ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke | Abstract similar documents |
| Dina Rustemovna Khasanova, Yu V Zhitkova | ||
| "... Цель исследования – сравнительный анализ частоты депрессии и когнитивных нарушений в ..." | ||
| Vol 12, No 4 (2020) | Depression and dementia: differentiation and comorbidity | Abstract similar documents |
| V. Yu. Lobzin, A. Yu. Emelin | ||
| "... Взаимосвязь когнитивных нарушений (КН) и депрессии сложна: депрессия может быть одним из симптомов ..." | ||
| Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
| I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
| "... Постинсультная депрессия значимо ухудшает функциональное восстановление пациентов и качество их ..." | ||
| Vol 8, No 2 (2016) | Therapy for depression in bipolar affective disorder | Abstract similar documents |
| N. A. Tyuvina, I. G. Korobkova | ||
| "... Цель исследования – оценить эффективность и безопасность различных схем терапии депрессии в ..." | ||
| Vol 9, No 3 (2017) | Clinical and psychopathological features of depressions with panic attacks | Abstract similar documents |
| N. N. Ivanets, K. M. Tartynsky, G. L. Krenkel, S. V. Prokhorova | ||
| "... Цель исследования – изучение клинико-психопатологических особенностей депрессий с паническими ..." | ||
| Vol 4, No 4 (2012) | Poststroke depression: prevalence, pathogenesis, diagnosis, and treatment | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... профилактике постинсультной депрессии. Депрессия развивается примерно у каждого 3-го больного, перенесшего ..." | ||
| Vol 17, No 2 (2025) | Cognitive impairment in depression and cerebrovascular disease | Abstract similar documents |
| I. V. Reverchuk | ||
| "... при депрессии, а также возможные терапевтические опции, позволяющие подобрать персонализированную ..." | ||
| Vol 14, No 2 (2022) | Clinical features of atypical depression in bipolar and recurrent affective disorders, psychogenic depression | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, M. S. Verbitskaya, G. I. Krenkel, E. N. Efremova | ||
| "... Цель исследования – сравнительное изучение клинических особенностей атипичной депрессии (АтД) при ..." | ||
| Vol 10, No 4 (2018) | Cognitive and motor training for patients with moderate cognitive impairment and mild dementia | Abstract similar documents |
| A. A. Naumenko, I. S. Preobrazhenskaya | ||
| "... of concomitant cardiovascular disease, the degree of apathy, adherence to the training, and the early initiation ..." | ||
| Vol 4, No 1 (2012) | Post-stroke depression: scientifically substantiated approaches to choosing therapy | Abstract similar documents |
| Yulia Aleksandrovna Starchina | ||
| "... Представлен обзор данных литературы об эпидемиологии постинсультной депрессии (ПД), ее ..." | ||
| Online-first | Predictive capabilities of the Temperament and Character Inventory (TCI) in assessing the effectiveness of antidepressant pharmacotherapy | Abstract similar documents |
| A. V. Ovchinnikov, T. I. Vazagaeva, R. V. Akhapkin, B. A. Volel | ||
| "... характера Клонингера в оценке результатов антидепрессивной фармакотерапии у больных с депрессией (большим ..." | ||
| Vol 8, No 4 (2016) | AFFECTIVE DISORDERS IN MYASTHENIA | Abstract similar documents |
| D. Yu. Konkova, V. N. Karnaukh | ||
| "... депрессии по шкале Цунга. Уточняли связь этих показателей с полом, возрастом, длительностью, степенью ..." | ||
| Vol 15, No 1 (2023) | Predictive capabilities of the Cloninger Temperament and Character Inventory (TCI) in evaluating the effectiveness of antidepressant pharmacotherapy. Systematic review and meta-analysis | Abstract similar documents |
| A. V. Ovchinnikov, T. I. Vazagaeva, R. V. Akhapkin, B. A. Volel | ||
| "... депрессией (большим депрессивным расстройством). Материал и методы. Поиск литературы проводился в системах ..." | ||
| Vol 12, No 6 (2020) | Post-stroke depression and the abilities of antidepressants to enhance the effectiveness of neurorehabilitation | Abstract similar documents |
| S. V. Kotov, E. V. Isakova, Yu. V. Egorova | ||
| "... Инсульт является основной причиной инвалидности во взрослой популяции. Депрессия после инсульта ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... Депрессия – одно из самых частых немоторных проявлений болезни Паркинсона (БП), во многом ..." | ||
| Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
| M. R. Nodel, N. N. Yakhno | ||
| "... Депрессия при болезни Паркинсона (БП) – одно из ведущих проявлений заболевания, снижающих качество ..." | ||
| Vol 3, No 3 (2011) | ICD-10 and the clinical features of depressions: data of the CIRCADIAN-I program | Abstract similar documents |
| O. V. Serdyuk, A. A. Ovchinnikov, N. A. Kutuzova, M. Yu. Drobizhev, K. Yu. Retyunsky | ||
| "... Данные исследования ЦИРКАДИАНI свидетельствуют о неудовлетворительной диагностике депрессий в ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... данный момент влияние депрессии на качество жизни (КЖ) больных РС мало изучено. Цель исследования ..." | ||
| Vol 16, No 5 (2024) | Humoral serotonin and neuropsychological status of patients with dizziness | Abstract similar documents |
| I. I. Borodulina, Yu. V. Karakulova | ||
| "... Головокружению часто сопутствуют аффективные расстройства в виде тревоги и депрессии, роль ..." | ||
| Vol 13, No 2 (2021) | Gender differences in the clinical course of depression in bipolar disorder | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, A. E. Stolyarova, D. V. Morozova, M. S. Verbitskaya | ||
| "... Цель исследования – изучение гендерных особенностей депрессии в рамках биполярного аффективного ..." | ||
| Vol 15, No 5 (2023) | Depressive disorders and their pharmacotherapy in routine clinical practice | Abstract similar documents |
| S. N. Mosolov, V. A. Parfenov, A. V. Amelin, V. E. Medvedev, V. D. Mendelevich, G. M. Usov, Yu. P. Sivolap, A. N. Bogolepova, E. A. Mkhitaryan, D. S. Petelin | ||
| "... Депрессия является одной из ведущих медицинских причин инвалидизации и смертности среди пациентов ..." | ||
| Vol 16, No 6 (2024) | Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy | Abstract similar documents |
| D. V. Zakharov, D. D. Kokareva | ||
| "... Депрессия и сиалорея относятся к числу наиболее частых и обременительных немоторных симптомов ..." | ||
| Vol 9, No 1 (2017) | Combination therapy for cognitive and emotional impairments in patients with arterial hypertension | Abstract similar documents |
| O. D. Ostroumova, E. A. Karavashkina | ||
| "... with arterial hypertension (AH). It stresses the importance of their correction to improve adherence ..." | ||
| Vol 13, No 4 (2021) | Postpartum depression — risk factors, clinical and treatment aspects | Abstract similar documents |
| M. A. Makarova, Yu. G. Tikhonova, T. I. Avdeeva, I. V. Ignatko, M. A. Kinkulkina | ||
| "... шкалы — Шкала оценки депрессии Монтгомери-Асберг, Шкала Гамильтона для оценки тревоги. Результаты и ..." | ||
| Vol 13, No 3 (2021) | From accurate diagnosis to targeted therapy: depression in general medical practice | Abstract similar documents |
| N. N. Petrova | ||
| "... депрессии Гамильтона. Результаты и обсуждение. Несмотря на значительную частоту и клиническую очерченность ..." | ||
| Vol 13, No 1 (2021) | Depression during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
| I. Yu. Dorozhenok | ||
| "... . Многофакторное стрессогенное воздействие пандемии COVID-19 спровоцировало экзацербацию депрессии у пациента с ..." | ||
| Vol 12, No 6 (2020) | Atypical depression in bipolar affective disorder: a clinical case study | Abstract similar documents |
| M. S. Verbitskaya, N. A. Tyuvina, G. L. Krenkel, E. N. Efremova, A. E. Stolyarova | ||
| "... Атипичная депрессия (АтД) противопоставляется классической эндогенной меланхолической депрессии и ..." | ||
| Vol 12, No 2 (2020) | Atypical depression: selection criteria, systematics, approaches to therapy | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, M. S. Verbitskaya, A. E. Stolyarova | ||
| "... Представлен обзор отечественной и зарубежной литературы, посвященной проблеме атипичной депрессии ..." | ||
| 1 - 70 of 264 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
